Methyldopa in treatment of neurogenic bladder disorders.
Fifty patients with neurogenic bladder dysfunction were treated with methyldopa (Aldomet). The preliminary results that are presented suggest a beneficial action in patients with upper neuron lesions. The probable mechanism of the drug's action is discussed.
D000320:Adrenergic Fibers / Q000187:drug effects; D001338:Autonomic Fibers, Postganglionic / Q000502:physiology; D006801:Humans; D008750:Methyldopa / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009046:Motor Neurons / Q000473:pathology; D013564:Sympathetic Nervous System / Q000502:physiology; D001743:Urinary Bladder / Q000294:innervation; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*
D008750:Methyldopa